Increasing evidence for omalizumab in the treatment of bullous pemphigoid
Saved in:
Main Authors: | Sarah Lonowski, MD, MBA (Author), Suzanne Sachsman, MD (Author), Nirali Patel, MS (Author), Allison Truong, MD (Author), Vanessa Holland, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid
by: Sébastien Menzinger, et al.
Published: (2017) -
Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based review
by: Abrahim Abduelmula, BScN, et al.
Published: (2022) -
Successful Treatment of a Bullous Pemphigoid Patient with Rituximab Who Was Refractory to Corticosteroid and Omalizumab Treatments
by: Aslı Bilgiç Temel, et al.
Published: (2017) -
Brunsting-Perry pemphigoid transitioning from previous bullous pemphigoid
by: Shengru Zhou, MD, PhD, et al.
Published: (2020) -
Semaglutide-associated bullous pemphigoid
by: Clayton P. Burruss, BS, et al.
Published: (2021)